EN DE
Watch Cuprina Holdings (Cayman) Limited Class A Ordinary Shares for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Cuprina Holdings (Cayman) Limited Class A (CUPR) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Cuprina Holdings (Cayman) Limited Class A stock $0.52, price $1.80, that is 71.1% below the price, quality 37 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in Singapore · ISIN KYG2592E1109

CH Cuprina Holdings (Cayman) Limited Class A logo Thin data Nov 6, 2026

Cuprina Holdings (Cayman) Limited Class A

CUPR · US
Very expensive, weak quality

Our calculation puts a fair price 71% below what the stock costs today.

Low debt
Fair value $0.5200 · Strongly overvalued
Quality 37/100
Weak Growth (revenue 3y −4.1 %/yr in SGD)
Negative free cash flow
Trails peers (2/6)
Narrow moat 38/100 · thin data
Thin data
Watch Cuprina Holdings (Cayman) Limited Class A Ordinary Shares for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$75.20 $1.60 Fair Value $0.5200 Apr 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

19‑month range $1.60 – $75.20 · fair‑value band $0.3400 – $0.6400 · the $1.80 price screens above the $0.5200 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in your weekly email

Every Wednesday you see whether Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.

Show moreShow less

The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.

It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste streams; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore.

Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Stock analysis

Cuprina Holdings (Cayman) Limited Class A (CUPR) currently trades at $1.80, while our model-based Fair Value estimate is $0.5200, 71% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $0.3400 (bear) to $0.6400 (bull), the price of $1.80 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares reported revenue of 49.9K SGD in FY2025 versus 58.5K SGD in FY2021, a compound −3.9%/yr. Reported net income was −4.7M SGD in FY2025.

Key figures

Market cap $14.7M Micro · EPS (TTM) $−1.40 · Return on equity −1,569% · Return on assets (EBIT) −71.0% (5-year average) · Operating margin −10,568% · Revenue (TTM) 49.9K SGD · Revenue growth (YoY) +267% · Free cash flow −9.2M SGD.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 79% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −71%, CUPR screens richer than that median.

Fair Value models

Bear $0.3400 Fair Value $0.5200 Bull $0.6400
Price $1.80 · Downside -71.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $0.3400 $0.5100 $0.6400 55
All 1 models by family
Asset-Based
NCAV (Graham) $0.3400 $0.5100 $0.6400 55

Open the full fair value analysis →

Quality Score breakdown

Overall quality 37/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 53
Are margins and returns getting better?
Cashflow 32
Do the profits arrive as real cash?
Financial strength 72
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 4
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 60
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+3.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−944.8% (2021) → −9,154.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

CUPR screens overvalued: fair value 71% below the price. Compare with Intuitive Surgical, Inc →

Compare Cuprina Holdings (Cayman) Limited Class A Ordinary Shares with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks

Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside −71.1% · Bottom 25%
Profitability
Return on assets −55.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 267.4% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 3.72× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 25
FUTURE (revenue growth)100 · sector 40
PAST (return on equity)0 · sector 30
HEALTH (low debt)99 · sector 96
DIVIDEND (yield)0 · sector 32

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.38 $131.27 +45% vs CUPR
EssilorLuxottica Société anonyme EL €193.80 €196.22 +1% vs CUPR
Intuitive Surgical, Inc ISRG $452.80 $353.90 −22% vs CUPR
Medline Inc MDLN $39.64 $28.59 −28% vs CUPR
Alcon Inc ALC CHF 61.30 CHF 34.06 −44% vs CUPR
Becton, Dickinson and Company BDX $211.88 $97.80 −54% vs CUPR
Straumann Holding STMN CHF 104.50 CHF 45.50 −56% vs CUPR
West Pharmaceutical Services, Inc WST $399.81 $139.22 −65% vs CUPR
Sartorius Stedim Biotech S.A DIM €225.80 €54.82 −76% vs CUPR
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs CUPR

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Fair Value". https://www.fairvalue-calculator.com/stock/CUPR

Frequently asked questions

Is Cuprina Holdings (Cayman) Limited Class A (CUPR) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $0.5200 versus a price of $1.80, about 71% lower (overvalued).
What is the fair value of CUPR?
Our model-based fair value for Cuprina Holdings (Cayman) Limited Class A is $0.5200 (as of Nov 6, 2026), built from audited fundamentals. The current price: $1.80.
What is the quality score of CUPR?
Cuprina Holdings (Cayman) Limited Class A has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Our model-based price target is the fair value of $0.5200 (as of Nov 6, 2026) from 1 valuation models. Cautious scenario $0.3400, optimistic scenario $0.6400. It is a calculation from audited fundamentals, not an analyst target.
What is the Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock forecast for 2026?
Our models put fair value at $0.5200, about 71% lower versus a price of $1.80 (overvalued). Cautious scenario $0.3400, optimistic scenario $0.6400. The calculation is refreshed regularly with new filings.
What is the revenue of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Cuprina Holdings (Cayman) Limited Class A reported trailing-twelve-month revenue of about 49.9K SGD (latest available figure, as of Nov 6, 2026).
What is the intrinsic value of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cuprina Holdings (Cayman) Limited Class A it is $0.5200 per share (as of Nov 6, 2026), against a price of $1.80. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock overvalued or undervalued in 2026?
As of Nov 6, 2026, CUPR trades above its calculated fair value: price $1.80, fair value $0.5200, a gap of about −71% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CUPR?
No. The price is what the market pays today ($1.80); the fair value is what the company's own numbers justify ($0.5200). For Cuprina Holdings (Cayman) Limited Class A the two are $1.28 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares worth?
The market values Cuprina Holdings (Cayman) Limited Class A at about $14.7M (market capitalisation, as of Nov 6, 2026). Per share that is $1.80; our models calculate a fair value of $0.5200 per share.
What do the bullish and bearish scenarios say about CUPR?
Our models span a range for Cuprina Holdings (Cayman) Limited Class A: cautious scenario $0.3400, base $0.5200, optimistic $0.6400 per share (as of Nov 6, 2026, price $1.80). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Balance-sheet figures for Cuprina Holdings (Cayman) Limited Class A (as of Nov 6, 2026): debt of 0.03 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is CUPR from its 52-week high?
Cuprina Holdings (Cayman) Limited Class A trades at $1.80, about 79% below its 52-week high of $8.41 and 13% above the low of $1.60 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5200 is for.
Which stocks are comparable to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock attractive at the current price?
The data as of Nov 6, 2026: price $1.80, calculated fair value $0.5200 (−71%), Quality Score 37/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CUPR calculated?
We run Cuprina Holdings (Cayman) Limited Class A through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $0.5200 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Cuprina Holdings (Cayman) Limited Class A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The closing price on Nov 6, 2026 was $1.80. Our model-based fair value is $0.5200, about 71% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cuprina Holdings (Cayman) Limited Class A Ordinary Shares right now?
The price sits above even our optimistic bull case ($0.6400). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.3400 to $0.6400) leaves room in how you read the outcome.

Key figures of Cuprina Holdings (Cayman) Limited Class A

How large is the market capitalisation of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The market capitalisation of Cuprina Holdings (Cayman) Limited Class A is $14.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Earnings per share at Cuprina Holdings (Cayman) Limited Class A are $−1.40. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The return on equity (ROE) of Cuprina Holdings (Cayman) Limited Class A is −1,569% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
On an EBIT basis the return on assets of Cuprina Holdings (Cayman) Limited Class A is −71.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cuprina Holdings (Cayman) Limited Class A (CUPR)?
The operating margin of Cuprina Holdings (Cayman) Limited Class A is −10,568% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cuprina Holdings (Cayman) Limited Class A (CUPR)?
Revenue at Cuprina Holdings (Cayman) Limited Class A is growing +267% versus a year earlier (3y avg −4.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Cuprina Holdings (Cayman) Limited Class A (CUPR) generate?
The free cash flow of Cuprina Holdings (Cayman) Limited Class A is −9.2M SGD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Cuprina Holdings (Cayman) Limited Class A (CUPR) hold?
Cuprina Holdings (Cayman) Limited Class A holds more cash than debt, 2.6M SGD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Cuprina Holdings (Cayman) Limited Class A Ordinary Shares in the live analysis

One click puts Cuprina Holdings (Cayman) Limited Class A Ordinary Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.